Waiting for new medicines in Canada, Europe and the United States 2016-2021

Canadian Health Policy Institute
Written by Guest User

The study compared the availability and wait for new medicines in Canada, the European Union and the United States. It examined new drug launches, regulatory approvals, and insurance coverage during the years 2016-2021.

Read the study

Guest User
Previous

SHIFT: Why do cancer patients have to jump through hoops to get life-saving medication?
Next

Canada’s hospital capacity crisis will remain long after the pandemic is over